During the past decade, Eola Eyes conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Eola Eyes" are "Ametropia" (2 trials), "Astigmatism" (2 trials), "Hyperopia" (2 trials), "Myopia" (2 trials) and "Presbyopia" (1 trials). Many other conditions were trialed in "Eola Eyes" in a lesser frequency.

Most popular intervention types in "Eola Eyes" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "APIOC Sphere and APIOC Astigmatism" (1 trials), "APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism" (1 trials), "Acuvue 2 Soft Contact Lens" (1 trials), "VISA (comfilcon A) Silicone Hydrogel Soft contact lens" (1 trials) and "alphafilcon A toric" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eola Eyes" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Eola Eyes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Eola Eyes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eola Eyes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".